34 studies found for:    " August 11, 2010":" September 10, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Circumcision, Male;   Patient Compliance;   Cellular Phone
Intervention: Other: Text Message
2 Completed
Has Results
A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Etravirine;   Drug: Ritonavir;   Drug: Darunavir
3 Completed Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure
Conditions: HIV;   AIDS;   Lopinavir;   Treatment Failure
Interventions: Drug: Ritonavir-boosted lopinavir;   Drug: optimized background regimens (OBRs)
4 Completed
Has Results
Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients
Condition: HIV Infections
Intervention:
5 Unknown  A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Conditions: HIV Infection;   Gastrointestinal Symptoms
Interventions: Dietary Supplement: GanedenBC30, GBI-30, PTA-6086;   Drug: Placebo
6 Completed Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?
Condition: HIV Infections
Intervention: Other: seaweed
7 Unknown  Reducing HIV in Adolescents
Condition: HIV Infections
Interventions: Behavioral: Cash incentives;   Behavioral: Life skills curriculum
8 Completed A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH)
Conditions: Sexually Transmitted Infections;   HIV Infections
Intervention: Behavioral: Experimental
9 Active, not recruiting Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia
Conditions: HIV Infection;   Tuberculosis;   Immunosuppression
Intervention:
10 Terminated Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Conditions: HIV Infection;   Mitochondrial Dysfunction
Interventions: Drug: Atazanavir/ritonavir;   Drug: Efavirenz
11 Completed The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance
Conditions: HIV-infection;   Pregnancy;   Mother to Child Transmission
Intervention: Drug: phenytoin
12 Active, not recruiting Affect Management for Early Adolescents
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
13 Completed
Has Results
A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
Conditions: Hepatitis C Infection;   HIV Infection
Intervention: Drug: Nitazoxanide With Pegylated Interferon And Ribavirin
14 Completed KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
Condition: Antiretroviral Therapy in HIV-1 Infected Children
Interventions: Drug: Kaletra dosed once daily;   Drug: kaletra dosed twice daily
15 Terminated Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 100 mg once daily;   Drug: GSK2248761 200 mg once daily;   Drug: Etravirine
16 Recruiting Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
Conditions: Adult Grade III Lymphomatoid Granulomatosis;   AIDS-related Diffuse Large Cell Lymphoma;   Contiguous Stage II Adult Diffuse Large Cell Lymphoma;   Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma;   Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma;   Contiguous Stage II Adult Lymphoblastic Lymphoma;   Contiguous Stage II Grade 3 Follicular Lymphoma;   Contiguous Stage II Mantle Cell Lymphoma;   HIV Infection;   Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;   Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma;   Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma;   Noncontiguous Stage II Adult Lymphoblastic Lymphoma;   Noncontiguous Stage II Grade 3 Follicular Lymphoma;   Noncontiguous Stage II Mantle Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Stage I Adult Diffuse Large Cell Lymphoma;   Stage I Adult Diffuse Mixed Cell Lymphoma;   Stage I Adult Immunoblastic Large Cell Lymphoma;   Stage I Adult Lymphoblastic Lymphoma;   Stage I Grade 3 Follicular Lymphoma;   Stage I Mantle Cell Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Mixed Cell Lymphoma;   Stage III Adult Immunoblastic Large Cell Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Mixed Cell Lymphoma;   Stage IV Adult Immunoblastic Large Cell Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Drug: vorinostat;   Drug: prednisone;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: etoposide;   Other: laboratory biomarker analysis;   Other: pharmacological study
17 Completed Atripla to Raltegravir Switch Study
Condition: HIV Infection
Intervention: Drug: Truvada/Raltegravir
18 Completed PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen
Condition: HIV Infection
Intervention: Drug: Maraviroc
19 Completed Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection
Condition: Acute HIV Infection
Intervention: Behavioral: Standard counseling
20 Recruiting The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
Condition: HIV
Intervention: Procedure: Lymph node biopsy

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years